V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016838 | 160008354 | 1.76 | 101 | Neo-adjuvant (N) | 2016-07-22 | 2016-07-22 | NIVOLUMAB | 02 | N | IXAZOMIB + LENALIDOMIDE | 100101467 |
| 160016839 | 160008355 | 1.82 | 60 | Palliative (P) | null | 2016-12-13 | Doxorubicin + Ifosfamide | 02 | N | NOT MATCHED | 100858860 |
| 160016841 | 160008356 | 1.86 | 85.8 | null | 2019-01-09 | 2019-01-23 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101515893 |
| 160016844 | 160008357 | 1.75 | 76.9 | null | 2016-02-20 | 2016-02-29 | Liposomal Doxorubicin (Caelyx) | 02 | 2 | EW EUROEWING 2012 ARM B VDC | 100517306 |
| 160016845 | 160008358 | 1.68 | 68 | 03 | 2017-05-01 | 2017-05-02 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + OLARATUMAB | 101401805 |
| 160016847 | 160008360 | 1.84 | 43.5 | Palliative (P) | 2017-06-19 | 2017-08-10 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101440899 |
| 160016849 | 160008361 | 1.61 | 73.4 | null | 2018-06-21 | 2018-06-21 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100471907 |
| 160016850 | 160008362 | 1.69 | 64.5 | Curative (C) | 2017-08-06 | 2017-10-07 | Gemcitabine day 1&8 | 02 | null | CARBOPLATIN + PACLITAXEL | 101449381 |
| 160016852 | 160008363 | 1.67 | 62 | Palliative (P) | 2016-08-06 | 2016-08-08 | BEP 3 day | 02 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100332645 |
| 160016853 | 160008364 | 1.66 | null | 03 | 2019-08-08 | 2019-08-09 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101322113 |
| 160016855 | 160008365 | 1.93 | 79.1 | Palliative (P) | 2015-02-02 | 2015-02-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | DOXORUBICIN | 101297903 |
| 160016858 | 160008367 | 1.78 | 78.3 | null | 2017-03-25 | 2017-03-25 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 100777333 |
| 160016861 | 160008368 | 1.68 | 77 | Palliative (P) | 2019-01-14 | 2019-01-16 | EW EuroEwing 2012 Arm A VIDE | 02 | N | DOXORUBICIN | 101034702 |
| 160016863 | 160008369 | 1.65 | 44.7 | null | 2018-04-14 | 2018-04-21 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100881898 |
| 160016864 | 160008370 | 1.74 | 72.9 | Curative (C) | 2017-07-26 | 2017-07-29 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100026642 |
| 160016866 | 160008372 | 1.7 | 82.5 | Palliative (P) | 2017-11-26 | 2017-11-27 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | null | DOXORUBICIN + IFOSFAMIDE | 101172983 |
| 160016867 | 160008373 | 1.68 | 85 | null | 2018-06-26 | 2018-06-26 | Liposomal Doxorubicin 50mg/m2 | 02 | N | DOXORUBICIN + OLARATUMAB | 100405415 |
| 160016868 | 160008374 | 1.68 | 95 | Curative (C) | 2019-09-23 | 2019-09-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101197738 |
| 160016869 | 160008375 | 1.85 | 93 | Palliative (P) | 2018-12-19 | 2018-12-19 | DOXORUBICIN | 01 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100954955 |
| 160016873 | 160008376 | 1.72 | 106 | Palliative (P) | 2018-08-14 | 2018-09-02 | Doxorubicin + Ifosfamide | 02 | N | NOT MATCHED | 100042010 |
| 160016877 | 160008377 | null | 58.6 | Palliative (P) | 2017-09-23 | 2017-10-06 | null | Y | N | NOT MATCHED | 100841815 |
| 160016881 | 160008378 | 1.74 | 57.6 | Palliative (P) | null | 2019-03-15 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOXORUBICIN + OLARATUMAB | 100221303 |
| 160016883 | 160008379 | 1.65 | 80.55 | Palliative (P) | 2016-05-20 | 2016-05-20 | Imatinib 400mg | N | N | EW EUROEWING 2012 ARM B VDC | 101350829 |
| 160016884 | 160008380 | 1.68 | 58 | null | 2018-08-21 | 2018-08-29 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 101006458 |
| 160016885 | 160008381 | null | 78.9 | Palliative (P) | 2018-08-06 | 2018-08-20 | Liposomal Doxorubicin (Caelyx) | N | N | DOXORUBICIN + IFOSFAMIDE | 101028116 |
| 160016887 | 160008382 | 1.69 | 100 | Palliative (P) | 2016-07-28 | 2016-08-14 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100948053 |
| 160016889 | 160008383 | 1.78 | 74.9 | Palliative (P) | 2016-01-20 | 2016-03-13 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100828540 |
| 160016891 | 160008384 | 1.53 | 79.3 | Palliative (P) | 2017-12-12 | 2017-12-12 | Liposomal Doxorubicin (Caelyx) | 02 | N | VINCRISTINE | 101294595 |
| 160016892 | 160008385 | 1.71 | 57.15 | Curative (C) | 2018-12-07 | 2018-12-07 | VDC | 02 | N | TRIAL | 100148793 |
| 160016893 | 160008386 | null | 30 | Palliative (P) | 2017-06-21 | 2017-06-21 | Doxorubicin + Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100280433 |
| 160016895 | 160008387 | 1.58 | 69.2 | Curative (C) | 2017-11-01 | 2017-11-02 | Doxorubicin 75mg/m2 | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100586589 |
| 160016898 | 160008388 | 1.75 | 91.4 | Palliative (P) | null | 2019-01-10 | Cisplatin + Pemetrexed | N | Y | CISPLATIN + PEMETREXED | 100348430 |
| 160016901 | 160008389 | 1.68 | 51.8 | Palliative (P) | 2022-01-17 | 2022-02-14 | Carboplatin AUC 2 - 5 | 2 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101762420 |
| 160016902 | 160008390 | 1.64 | 75.4 | null | 2019-05-30 | 2019-07-05 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN | 100028804 |
| 160016906 | 160008391 | 1.71 | 70 | Curative (C) | 2018-05-29 | 2018-06-01 | Liposomal Doxorubicin (Caelyx) | 02 | N | IMATINIB | 101145806 |
| 160016909 | 160008392 | 1.68 | null | Curative (C) | 2017-12-07 | 2017-12-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100266040 |
| 160016910 | 160008393 | 1.74 | 57 | Neo-adjuvant (N) | 2015-03-12 | 2015-03-14 | CARBOPLATIN + PACLITAXEL | 02 | N | DOXORUBICIN | 100546535 |
| 160016911 | 160008394 | 1.8 | 75.4 | Adjuvant (A) | 2019-01-01 | 2019-01-03 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101465287 |
| 160016912 | 160008395 | 1.66 | 60.7 | Neo-adjuvant (N) | 2017-05-23 | 2017-06-15 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100070826 |
| 160016913 | 160008396 | 1.79 | 55.6 | 03 | 2013-12-31 | 2013-12-31 | VAC | 01 | N | LIPOSOMAL DOXORUBICIN | 101688532 |
| 160016914 | 160008397 | 1.65 | 47.3 | null | 2017-03-31 | 2017-04-08 | Cyclophosphamide oral | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 101839026 |
| 160016915 | 160008398 | 1.51 | 69.4 | null | 2020-09-19 | 2020-10-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101636097 |
| 160016921 | 160008399 | 1.73 | 80.3 | Palliative (P) | null | 2020-07-23 | GemCarbo Days 1+8 | N | N | DOXORUBICIN | 100601969 |
| 160016923 | 160008400 | 1.59 | 69.3 | Palliative (P) | 2016-05-27 | 2016-06-16 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 100612536 |
| 160016926 | 160008401 | 1.75 | 64.6 | Palliative (P) | 2016-04-21 | 2016-05-17 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100342029 |
| 160016927 | 160008402 | 1.6 | 89 | Palliative (P) | 2017-04-30 | 2017-05-21 | Carboplatin AUC 2 - 5 | 2 | N | CARBOPLATIN | 101006387 |
| 160016928 | 160008403 | 1.76 | 86 | Palliative (P) | 2016-07-27 | 2016-08-04 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 100225062 |
| 160016932 | 160008404 | null | 68.85 | Palliative (P) | 2017-09-20 | 2017-09-22 | Carboplatin + Paclitaxel (3 weekly) | 99 | null | CARBOPLATIN + PACLITAXEL | 100082815 |
| 160016935 | 160008405 | 1.65 | 115 | Palliative (P) | 2018-04-21 | 2018-05-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101014869 |
| 160016938 | 160008406 | 1.72 | 66.3 | Palliative (P) | 2022-01-10 | 2022-01-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100994658 |